“Evaluation of Thrombolysis in Acute St Elevation Myocardial Infarction in Sir T. Hospital, Bhavnagar.”

Abstract

INTRODUCTION: Acute ST elevation myocardial infarction (STEMI) occurs most commonly when thrombus formation causes occlusion of a major coronary vessel. Thrombolytic therapy is a signicant advancement in the treatment of STEMI. Clinical trials have established the safety and efcacy of thrombolytic therapy in STEMI when administered within 12 hours of the onset of symptoms; the earlier it is administered, the greater the benet. METHODOLOGY: A Cross-sectional observational study was carried out at Sir T. Hospital, Bhavnagar. 100 Acute STEMI (ST elevation myocardial infarction) patients admitted in ICCU during august 2021 to July 2022 after taking informed written consent were subjected to detailed history and complete physical examination and data collected was noted in a predesigned Performa. Among 100 patients, majority of the cases were in age group of 51 to 60 yrs RESULTS: . Male patients are predominantly affected than female patients. IV Streptokinase thrombolytic therapy in acute STEMI pa CONCLUSION: tients within golden hours improved the reperfusion of myocardium and also associated with reduction of adverse events and decreased mortality.